Date published: 2025-12-5

1-800-457-3801

SCBT Portrait Logo
Seach Input

Fmoc-Dap-OH (CAS 181954-34-7)

0.0(0)
Write a reviewAsk a question

Alternate Names:
Nα-Fmoc-L-2,3-diaminopropionic acid
Application:
Fmoc-Dap-OH is an Fmoc-protected compound for proteomics research
CAS Number:
181954-34-7
Molecular Weight:
326.35
Molecular Formula:
C18H18N2O4
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Fmoc-Dap-OH is an Fmoc-protected compound for proteomics research. Fmoc-Dap-OH is an amino acid derivative employed in peptide and protein synthesis. Its versatility as a reagent in organic synthesis makes it a key component in peptide synthesis methods, including solid-phase synthesis, solution-phase synthesis, and native chemical ligation.


Fmoc-Dap-OH (CAS 181954-34-7) References

  1. The synthesis and study of side-chain lactam-bridged peptides.  |  Taylor, JW. 2002. Biopolymers. 66: 49-75. PMID: 12228920
  2. Conformationally constrained CCK8 analogues obtained from a rationally designed peptide library as ligands for cholecystokinin type B receptor.  |  De Luca, S., et al. 2006. ChemMedChem. 1: 997-1006. PMID: 16915602
  3. Assessment of structurally diverse philanthotoxin analogues for inhibitory activity on ionotropic glutamate receptor subtypes: discovery of nanomolar, nonselective, and use-dependent antagonists.  |  Frølund, S., et al. 2010. J Med Chem. 53: 7441-51. PMID: 20873775
  4. Synthetic strategy for side chain mono-N-alkylation of Fmoc-amino acids promoted by molecular sieves.  |  Monfregola, L. and De Luca, S. 2011. Amino Acids. 41: 981-90. PMID: 21069398
  5. TRPV1 modulators: structure-activity relationships using a rational combinatorial approach.  |  Zaccaro, L., et al. 2011. Bioorg Med Chem Lett. 21: 3541-5. PMID: 21612926
  6. Elucidation of the contribution of active site and exosite interactions to affinity and specificity of peptidylic serine protease inhibitors using non-natural arginine analogs.  |  Hosseini, M., et al. 2011. Mol Pharmacol. 80: 585-97. PMID: 21719463
  7. Structure-based design of covalent Siah inhibitors.  |  Stebbins, JL., et al. 2013. Chem Biol. 20: 973-82. PMID: 23891150
  8. Synthesis of an azido precursor to (2S,5R)-5-hydroxylysine using an asymmetric organocatalytic chlorination/reduction sequence.  |  Johannes, M. and Brimble, MA. 2013. J Org Chem. 78: 12809-13. PMID: 24175670
  9. Selective sensing of pyrophosphate in physiological media using zinc(II)dipicolylamino-functionalised peptides.  |  Zwicker, VE., et al. 2015. Org Biomol Chem. 13: 7822-9. PMID: 26107804
  10. Stable and Potent Selenomab-Drug Conjugates.  |  Li, X., et al. 2017. Cell Chem Biol. 24: 433-442.e6. PMID: 28330604
  11. Diversity-Oriented Syntheses by Combining CuAAC and Stereoselective INCIC Reactions with Peptides.  |  Wang, Y., et al. 2017. Chemistry. 23: 13869-13874. PMID: 28833706
  12. Modified Peptide Inhibitors of the Keap1-Nrf2 Protein-Protein Interaction Incorporating Unnatural Amino Acids.  |  Georgakopoulos, ND., et al. 2018. Chembiochem. 19: 1810-1816. PMID: 29927029
  13. Synthesis, Antiproliferative Activity, and DNA Binding Studies of Nucleoamino Acid-Containing Pt(II) Complexes.  |  Riccardi, C., et al. 2020. Pharmaceuticals (Basel). 13: PMID: 33007911
  14. Construction of diverse peptide structural architectures via chemoselective peptide ligation.  |  Cheung, CHP., et al. 2021. Chem Sci. 12: 7091-7097. PMID: 34123337
  15. Synthesis of a radioiodinated photoreactive MAGE-1 peptide derivative and photoaffinity labeling of cell-associated human leukocyte antigen-A1 molecules.  |  Anjuère, F., et al. 1995. Anal Biochem. 229: 61-7. PMID: 8533896

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Fmoc-Dap-OH, 1 g

sc-228181
1 g
$101.00